Aluna is a San Francisco digital health company that turns daily breathing into data. Its FDA-cleared, palm-sized spirometer pairs with a gamified app and a clinician dashboard so people with asthma, COPD and cystic fibrosis - and their doctors - can track lung function (FEV1) at home and catch trouble before it becomes an emergency. Founded by three UC Berkeley alumni and originally named Knox Medical Diagnostics, Aluna raised about $27M total, including a $15.3M Series B in 2023, and was acquired by Huma in May 2025.
Charvi Shetty is the co-founder and CEO of Aluna, a San Francisco respiratory-health company that makes an FDA-cleared, pocket-sized spirometer paired with games and AI so patients can track lung function from home and send the data to their doctors. A UC Berkeley bioengineer with a UCSF master's in biomedical imaging, she left an algorithm-engineering job at Genentech to build the device, became the youngest recipient of an NSF SBIR grant, and is recognized as one of the youngest female CEOs to bring an FDA-cleared healthtech device to market. In 2023 Aluna raised a $15.3M Series B, bringing total funding to about $27M.
NuvoAir Medical is a virtual-first cardiopulmonary care company that helps patients with chronic heart and lung conditions - COPD, asthma, and CHF - manage their health from home before they end up in a hospital. Founded in Stockholm in 2015-2016 by Lorenzo Consoli and now headquartered in Boston, NuvoAir pairs FDA-cleared connected devices like the Air Next home spirometer with a clinical care team and data-driven monitoring. Its model is built around value-based care, with studies showing meaningful reductions in medical spend and hospitalizations. The company also powers decentralized clinical trials for pharma partners.